Riffyn Blog

Category: Perspectives

Riffyn's 5 Most Popular Blog Posts of All Time
Embriette Hyde

Since we love data, we dived into our content analytics to learn about topics that you love to read — and those you don’t. Using Google Analytics, we determined our 5 most popular blog posts of all time. We welcome you to take a walk down memory lane and visit (or revisit) our most popular articles of all time!

Riffyn Makes Machine Learning in Science an Everyday Reality
Riffyn Team
The barrier to unlocking the full potential of machine learning isn’t bad analytical tools or fear of statistics: it’s bad data resulting from poorly designed studies. Using scientific blueprints to organize people, process, tech, & data, Riffyn makes machine learning in science an everyday reality.
Process Development Data Innovations Are Speeding the Path to Market for Novel Therapies
Riffyn Team
The 6th Accelerating Biopharmaceutical Development Conference (AccBio2019), hosted by AIChE from February 17-19, 2019 focused on the confluence of new therapy pathways, biologics process intensification, and using process development data to speed innovative therapies to market.
Digital Publishing Isn't Enough: the Case for "Blueprints" in Scientific Communication
Timothy Gardner
If modern software engineering worked like science, programmers would not share open source code, they would take notes on their work and then publish long-form articles about their software. Months or years later, their colleagues would attempt to reproduce the software based on the article.
Process Models are Leading the Way in Bioprocess Development
Riffyn Team
The BioProcess International West conference, held in San Francisco CA from March 19-22 2018, reinforced the state of the bioprocess industry for biotech companies looking to accelerate and intensify their manufacturing processes. Here we discuss ways companies are taking action towards their goals.

Shorter Time to Market is Reshaping Biopharma R&D
Riffyn Team
The Global Bioproduction Summit held in San Diego California from February 5-6, 2018 detailed the most pressing issues in biologics manufacturing. A dominant theme at this conference was drug makers’ focus on reducing the time to market for new drugs.

Sign up for Riffyn News

Follow Riffyn on our journey to help R&D teams discover more.

By submitting your information, you agree to the processing of your personal data by Riffyn as described in Riffyn's Privacy Policy.

2X faster to market

Novozymes delivers four break-through biofuels products to market in half the normal development time with transformative digital infrastructure.

Get the case study


Honoring Juneteenth by Supporting Our Communities

Read more on the blog


NanoCanada From Earth to Space Virtual Launch Celebration

See more events